Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04658368 · ClinicalTrials.gov registry record
Patient Reported Outcomes Following Targeted Muscle Reinnervation
A clinical trial, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- 2
- Enrollment target
NCT04658368: Clinical Trial study, sponsored by University of Wisconsin, Madison.
NCT04658368 is a clinical trial that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04658368 was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize the functional status and quality of life of patients undergoing Targeted Muscle Reinnervation (TMR) at time of major limb amputation (primary) or subsequent to major limb amputation (secondary). Participants can expect to be on study for about a year and will complete a short electronic survey and option phone interview.
Primary Outcome
The functional status and quality of life of patients who have undergone primary or secondary TMR will be measured using patient reported outcome instruments. 25-items scored on a 5 point likert scale will be combined for a score between 25 and 125, where higher scores indicate better quality of life. Items represent combined tools of the following PROMIS instruments: Ability to participate in social roles and activities, Global health, Pain intensity, self-efficacy for management chronic condit
Interventions
- PROCEDURE Primary TMR
- PROCEDURE Secondary TMR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2020-12-29 |
| Est. Completion | 2022-09-01 |
Why NCT04658368 stopped before completion
NCT04658368 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Primary TMR is the first listed.
NCT04658368 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04658368 about?
NCT04658368 is a clinical study titled "Patient Reported Outcomes Following Targeted Muscle Reinnervation". The purpose of this study is to characterize the functional status and quality of life of patients undergoing Targeted Muscle Reinnervation (TMR) at time of major limb amputation (primary) or subsequent to major limb amputation (secondary). Participants can expect to be on study for about a year and...
What is the current status of trial NCT04658368?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2020-12-29. Estimated completion is 2022-09-01.
What interventions are being tested in trial NCT04658368?
The interventions under investigation include: Primary TMR (PROCEDURE), Secondary TMR (PROCEDURE).
Who is sponsoring clinical trial NCT04658368?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI